These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 3009703)

  • 1. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated hepatitis A vaccine: active and passive immunoprophylaxis in chimpanzees.
    Purcell RH; D'Hondt E; Bradbury R; Emerson SU; Govindarajan S; Binn L
    Vaccine; 1992; 10 Suppl 1():S148-51. PubMed ID: 1335648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further evaluation of a live hepatitis A vaccine in marmosets.
    Provost PJ; Banker FS; Wadsworth CW; Krah DL
    J Med Virol; 1991 Aug; 34(4):227-31. PubMed ID: 1658214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of prototype live hepatitis A virus vaccines in primate models.
    Karron RA; Daemer R; Ticehurst J; D'Hondt E; Popper H; Mihalik K; Phillips J; Feinstone S; Purcell RH
    J Infect Dis; 1988 Feb; 157(2):338-45. PubMed ID: 2826614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody response to nonstructural proteins of hepatitis A virus following infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    J Med Virol; 1993 May; 40(1):76-82. PubMed ID: 8390561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a live attenuated hepatitis A virus vaccine in seronegative volunteers.
    Midthun K; Ellerbeck E; Gershman K; Calandra G; Krah D; McCaughtry M; Nalin D; Provost P
    J Infect Dis; 1991 Apr; 163(4):735-9. PubMed ID: 1849160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A trial of a cultured inactivated vaccine against hepatitis A on Saguinus mystax tamarins].
    Poleshchuk VF; Balaian MS; Sobol' AV; Titova IP; Guliaeva TV; Dokin VP; Kusov IuIu
    Vopr Virusol; 1990; 35(4):296-9. PubMed ID: 2256314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity trial of inactivated hepatitis A virus vaccine in human volunteers.
    Kusov YuYu ; Elbert LB; Nelga IV; Grishina GK; Dunaevski OA; Kharin NV; Maslov YuN ; Drozdov SG; Balayan MS
    Vaccine; 1991 Aug; 9(8):540-1. PubMed ID: 1663301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible approaches to develop vaccines against hepatitis A.
    D'Hondt E
    Vaccine; 1992; 10 Suppl 1():S48-52. PubMed ID: 1335659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunogenicity of a cultured inactivated hepatitis A vaccine].
    Kusov IuIu; El'bert LB; Kazachkov IuA; Val'iano NM; Nel'ga IV; Grishina GK; Krutianskaia GL; Lisitsyna EA; Poleshchuk VF; Sobol' AV
    Vopr Virusol; 1991; 36(3):206-9. PubMed ID: 1654007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibodies to the nonstructural 3C proteinase of hepatitis A virus.
    Stewart DR; Morris TS; Purcell RH; Emerson SU
    J Infect Dis; 1997 Sep; 176(3):593-601. PubMed ID: 9291304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an inactivated hepatitis A vaccine in pre- and postexposure conditions in marmosets.
    D'Hondt E; Purcell RH; Emerson SU; Wong DC; Shapiro M; Govindarajan S
    J Infect Dis; 1995 Mar; 171 Suppl 1():S40-3. PubMed ID: 7876647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological approaches to distinguish immune response to hepatitis A vaccine and natural infection.
    Robertson BH; Jia XY; Tian H; Margolis HS; Summers DF; Ehrenfeld E
    Vaccine; 1992; 10 Suppl 1():S106-9. PubMed ID: 1335637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile.
    Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL
    Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vaccination against hepatitis A].
    Giusti G; Russo M
    Recenti Prog Med; 1992 Jun; 83(6):313-20. PubMed ID: 1323136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A.
    Flehmig B
    Baillieres Clin Gastroenterol; 1990 Sep; 4(3):707-20. PubMed ID: 1962730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immune response to different doses of inactivated hepatitis A vaccine.
    Jilg W; Bittner R; Schätzl H; Rasshofer R; Schmidt M; Deinhardt F
    J Hepatol; 1993; 18 Suppl 2():S38-40. PubMed ID: 8182271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.